medigraphic.com
Boletín Médico del Hospital Infantil de México

2008, Number 1

<< Back Next >>

Bol Med Hosp Infant Mex 2008; 65 (1)

Gastrointestinal alterations in patients with Down syndrome

Morán-Barroso VF, Gil-Rosales CA, García-Delgado C, Nieto-Zermeño J, Vizcaíno-Alarcón A, Pacheco-Ríos A, Pérezpeña-Díazconti M

Language: Spanish
References: 16
Page: 36-48
PDF size: 210.74 Kb.


Text Extraction

No abstract


REFERENCES

  1. Singh MV, Richards C, Bowen JC. Does Down syndrome affect the outcome congenital duodenal obstruction? Pediatr Surg Int. 2004; 20: 580-9.

  2. Roizen NJ, Patterson D. Down syndrome. Lancet. 2003; 361: 1281-9.

  3. Garrison MM, Jeffriesh H, Christakis DA. Risk of death for children with Down syndrome and sepsis. J Pediatr. 2005; 147: 723-5.

  4. Barrat TM, Niaudet P. Clinical evaluation. En: Avner ED, Harmos WE, Niaudet P, editores. Pediatric nephrology, 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2004. p. 387.

  5. Siegel NJ, Scott K, Van W, Deverajan P. Pathogenesis of acute renal failure. En: Avner ED, Harmos WE, Niaudet P, editores. Pediatric nephrology. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2004. p. 1223.

  6. Cleves MA, Hobbs CA, Cleves PA, Tilford JM, Bird TM, Robbins JM. Congenital defects among live born infants with Down syndrome. Birth Defects Res A Clin Mol Teratol. 2007; 79: 657-63.

  7. Quinn FM, Surana R, Puri P. The influence of trisomy 21 on outcome in children with Hirschsprung´s disease. J Pediatr Surg. 1994; 29: 781-3.

  8. Swigonski NL, Kuhlenschmidt HL, Bull MJ, Corkins MR, Downs SM. Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma. Pediatrics. 2006; 118: 594-602.

  9. van Trotsenburg AS, Heymans HS, Tijssen JG, de Vijlder JJ, Vulsma T. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome. Pediatrics. 2006; 118: 1633-9.

  10. Vizcaíno-Alarcón A, Ortega-López R. Etiología de las cardiopatías congénitas. Bol Med Hosp Infant Mex. 1974; 31: 373-83.

  11. Douglas S. Down syndrome: immunologic and epidemiologic associations-enigmas remain. J Pediatr. 2005; 147: 723-5.

  12. Cuadrado E, Barrena MJ. Immune dysfunction in Down’s syndrome: primary immune deficiency or early senecescence of the immune system? Clin Immunol Immunopathol. 1996; 78: 209-14.

  13. Lineamiento técnico 2007. Atención integral de la persona con síndrome de Down. México, D. F.: Secretaría de Salud. Centro Nacional de Equidad de Género y Salud Reproductiva; 2007.

  14. Hattori M. The DNA sequence of human chromosome 21. Nature. 2000; 405: 311-9.

  15. Rachidi M, Lopes C. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. Neurosci Res. 2007; 59: 349-69.

  16. Benn PA, Campbell WA, Zelop CM, Ingardia C, Egan JF. Stepwise sequential screening for fetal aneuploidy. Am J Obstet Gynecol. 2007; 197: 312.e1-312.e5.




2020     |     www.medigraphic.com